Since decreased MTP expression has been reported in NAFLD, especially in non-alcoholic steatohepatitis [32,33,34], the combination of increased MTP and augmented β-oxidation might attenuate hepatic fat accumulation. The gene discussed is MTTP; the disease is metabolic dysfunction-associated steatotic liver disease.